The present invention relates to novel quinoline derivatives such as compounds of the formula (I) which possess are capable of selectively modulating the cannabinoid 2 receptor:
and the use of such compounds or pharmaceutical compositions thereof in the treatment of CNS disorders.
本发明涉及新型
喹啉衍
生物,例如式(I)的化合物,其具有选择性调节
大麻素2受体的能力。同时还涉及这些化合物或其药物组成物在治疗中枢神经系统疾病方面的用途。